Current pharmacologic therapies and emerging alternatives in the treatment of ulcerative colitis

Tetsuya Nakamura, Masakazu Nagahori, Takanori Kanai, Mamoru Watanabe

研究成果: Article査読

4 被引用数 (Scopus)

抄録

Recent progress in both basic and clinical research has led us to develop sophisticated and effective medical therapy of ulcerative colitis (UC). Although classical agents such as aminosalicylates, corticosteroids and immunomodulatory drugs have remained as the gold standard for decades, their novel formulations and/or dosage regimens have changed their placements in the medical management of UC. In addition, studies have shown that a number of novel therapeutic agents, designed to target specific mechanisms involved in the inflammatory cascade, have efficacy for the treatment of UC and they will have significant clinical impacts in the near future. A clear understanding of the proven and potential benefits of both the standard and emerging therapies will be required for the optimum individual care of patients with varied clinical presentations.

本文言語English
ページ(範囲)36-41
ページ数6
ジャーナルDigestion
77
SUPPL. 1
DOI
出版ステータスPublished - 2008 1
外部発表はい

ASJC Scopus subject areas

  • 消化器病学

フィンガープリント

「Current pharmacologic therapies and emerging alternatives in the treatment of ulcerative colitis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル